Lenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.
Donna Weber, Michael Wang, Christine Chen, Andrew R. Belch, Edward A. Stadtmauer, Ruben Niesvisky, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight, Meletios A Dimopoulos (2006). Lenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.. , 108(11), DOI: https://doi.org/10.1182/blood.v108.11.3547.3547.
